ATE101854T1 - Spirocyclische antipsychotische mittel. - Google Patents

Spirocyclische antipsychotische mittel.

Info

Publication number
ATE101854T1
ATE101854T1 AT90202012T AT90202012T ATE101854T1 AT E101854 T1 ATE101854 T1 AT E101854T1 AT 90202012 T AT90202012 T AT 90202012T AT 90202012 T AT90202012 T AT 90202012T AT E101854 T1 ATE101854 T1 AT E101854T1
Authority
AT
Austria
Prior art keywords
sychotic
spirocyclic
agents
spiro
piperidine
Prior art date
Application number
AT90202012T
Other languages
English (en)
Inventor
David Charles Billington
Mark Stuart Chambers
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE101854T1 publication Critical patent/ATE101854T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
AT90202012T 1989-07-26 1990-07-23 Spirocyclische antipsychotische mittel. ATE101854T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917069A GB8917069D0 (en) 1989-07-26 1989-07-26 Therapeutic agents

Publications (1)

Publication Number Publication Date
ATE101854T1 true ATE101854T1 (de) 1994-03-15

Family

ID=10660644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90202012T ATE101854T1 (de) 1989-07-26 1990-07-23 Spirocyclische antipsychotische mittel.

Country Status (17)

Country Link
EP (1) EP0414289B1 (de)
JP (1) JPH03184959A (de)
KR (1) KR910002444A (de)
AT (1) ATE101854T1 (de)
AU (1) AU628612B2 (de)
CA (1) CA2021736A1 (de)
DE (1) DE69006799T2 (de)
DK (1) DK0414289T3 (de)
ES (1) ES2062303T3 (de)
FI (1) FI903728A7 (de)
GB (1) GB8917069D0 (de)
IE (1) IE902706A1 (de)
IL (1) IL95124A0 (de)
NO (1) NO903315L (de)
NZ (1) NZ234557A (de)
PT (1) PT94806A (de)
ZA (1) ZA905841B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445974A3 (en) * 1990-03-05 1992-04-29 Merck Sharp & Dohme Ltd. Spirocyclic antipsychotic agents
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
JPH08502474A (ja) * 1992-10-07 1996-03-19 メルク エンド カンパニー インコーポレーテッド トコリティックオキシトシンレセプターアンタゴニスト
US5670509A (en) * 1993-09-27 1997-09-23 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
WO1995028389A1 (en) * 1994-04-15 1995-10-26 Yamanouchi Pharmaceutical Co., Ltd. Spiro compound and medicinal composition thereof
SK17512001A3 (sk) * 1999-06-07 2002-11-06 Warner-Lambert Company Tricyklické analgetiká
US7045527B2 (en) 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
EA011010B1 (ru) 2004-02-27 2008-12-30 Эмджен, Инк. Соединения, модулирующие рецептор gpr40, фармацевтическая композиция, способ лечения заболеваний, чувствительных к модулированию рецептора gpr40 (варианты), способ модулирования функции gpr40 (варианты) и способ модулирования циркулирующей концентрации инсулина
US7786141B2 (en) 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
KR20070046929A (ko) * 2004-08-19 2007-05-03 버텍스 파마슈티칼스 인코포레이티드 무스카린 수용체 조절제
BRPI0514736A (pt) 2004-08-27 2008-06-24 Esteve Labor Dr inibidores do receptor sigma
EP1781618B1 (de) 2004-08-27 2012-10-03 Laboratorios Del Dr. Esteve, S.A. Sigmarezeptor-inhibitoren
EP1634873A1 (de) 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Sigmarezeptor-Inhibitoren
RU2417987C2 (ru) 2004-08-27 2011-05-10 Лабораторьос Дель Др.Эстеве, С.А. Ингибиторы сигма-рецептора
RU2007124373A (ru) 2004-11-29 2009-01-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Модуляторы мускариновых рецептеров
EP1924546A1 (de) 2005-09-14 2008-05-28 Amgen, Inc Konformationseingeschränkte 3- (4-hydroxy-phenyl) substitutierte propansäuren zur behandlung von stoffwechselstörungen
JP2009521483A (ja) 2005-12-22 2009-06-04 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
EP1987034B1 (de) 2006-02-22 2011-07-20 Vertex Pharmceuticals Incorporated Kondensierte spiropiperidine als modulatoren muskarinartiger rezeptoren
AU2007221214A1 (en) 2006-02-22 2007-09-07 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
JP2009528315A (ja) 2006-03-01 2009-08-06 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ シグマ受容体阻害剤としてのピラゾール誘導体
EP1829875A1 (de) 2006-03-01 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Pyrazolderivate als Inhibitoren des Sigma-Rezeptors
EP1829866A1 (de) 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Inhibitoren von Sigmarezeptoren
EP1829867A1 (de) 2006-03-03 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Gegenüber dem Sigmarezeptor pharmazeutisch aktive Imidazolverbindungen
CN101500565A (zh) 2006-06-29 2009-08-05 弗特克斯药品有限公司 毒蕈碱性受体的调节剂
AU2007284548A1 (en) 2006-08-15 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP2051715A2 (de) 2006-08-18 2009-04-29 Vertex Pharmceuticals Incorporated Modulatoren muskarinischer rezeptoren
AU2007293028B2 (en) 2006-09-07 2012-05-31 Amgen Inc. Heterocyclic GPR40 modulators
US7687526B2 (en) 2006-09-07 2010-03-30 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
CA2683751C (en) 2007-04-16 2013-01-08 Amgen Inc. Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
US7973162B2 (en) 2007-10-03 2011-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
KR20100090249A (ko) 2007-10-10 2010-08-13 암젠 인크 치환된 비페닐 grp40 조절제
US8450522B2 (en) 2008-03-06 2013-05-28 Amgen Inc. Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
EP2116539A1 (de) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-Aryl-3-Amino-alkoxy-pyrazole als Sigma-Liganden zur Verbesserung der analgetischen Wirkung von Opioiden und zur Schwächung der Abhängigkeit davon
US8748462B2 (en) 2008-10-15 2014-06-10 Amgen Inc. Spirocyclic GPR40 modulators
EP2353591A1 (de) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Verstärkung der analgesischen Wirkung von Opioden und Opiaten bei postoperativem Schmerz und zur Schwächung der Abhängigkeit davon
EP2353598A1 (de) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Anwendung in der Vorbeugung und/oder Behandlung von postoperativem Schmerz
EP2388005A1 (de) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Vorbeugung und/oder Behandlung von Erbrechen infolge von Chemotherapie oder Strahlentherapie
EP2395003A1 (de) 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Pyrazolverbindungen als Sigmarezeptor-Inhibitoren
EP2415471A1 (de) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Sigmaliganden bei opioidinduzierter Hyperalgesie
EP2524694A1 (de) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Sigmaliganden bei Schmerz im Zusammenhang mit Typ-2-Diabetes
TW201607538A (zh) 2013-12-17 2016-03-01 以斯提夫博士實驗室股份有限公司 血清素-去甲腎上腺素再攝取抑制劑(SNRIS)和σ受體配體組合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides

Also Published As

Publication number Publication date
FI903728A0 (fi) 1990-07-25
NZ234557A (en) 1992-12-23
IE902706A1 (en) 1991-02-27
ES2062303T3 (es) 1994-12-16
NO903315L (no) 1991-01-28
EP0414289B1 (de) 1994-02-23
PT94806A (pt) 1991-03-20
EP0414289A1 (de) 1991-02-27
DK0414289T3 (da) 1994-04-11
GB8917069D0 (en) 1989-09-13
NO903315D0 (no) 1990-07-25
IL95124A0 (en) 1991-06-10
AU628612B2 (en) 1992-09-17
ZA905841B (en) 1991-06-26
CA2021736A1 (en) 1991-01-27
FI903728A7 (fi) 1991-01-27
KR910002444A (ko) 1991-02-25
JPH03184959A (ja) 1991-08-12
AU5984490A (en) 1991-01-31
DE69006799T2 (de) 1994-08-11
DE69006799D1 (de) 1994-03-31

Similar Documents

Publication Publication Date Title
DE69006799D1 (de) Spirocyclische antipsychotische Mittel.
DE69022567D1 (de) Polycarbonat-polydimethylsiloxan copolymer und herstellungsverfahren.
DE69014357D1 (de) Fahrzeug-Steuervorrichtung und Steuerverfahren.
DE68905846D1 (de) Gesaettigte laugen zur behandlung von bohrloechern und additive dafuer.
DE68912148D1 (de) Fahrzeug-Wechselstromgenerator und Herstellungsverfahren.
DE69014030D1 (de) Mittel für die Verhütung und Behandlung von Diarrhöe.
DE69000467D1 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
ATE47853T1 (de) 5,6-difluornaphtyridine und 5,6,8trifluorchinoline verwendbar als antibakterielle mittel.
DE58900363D1 (de) Vorrichtung zum aufrichten und aufreihen von formteilen.
DE69003548D1 (de) Transparente schweisshemmende mittel und herstellungsverfahren.
ATE86490T1 (de) Tracheobronchodilatator.
EP0410535A3 (de) Octahydrobenzisochinolin-Derivate als antipsychotische Mittel
DE69637363D1 (de) 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on-derivate mit pde iv und cytokin-inhibirendes aktivität
DE68906620D1 (de) Luftreifen-felgen-einheit und luftreifen dafuer.
DE3887345D1 (de) Fluoriertes copolymer und sperrschichten.
DE68908037D1 (de) Polyaetherimid-mischungen und formverfahren.
DE3773528D1 (de) Vorrichtung zum absorbieren von stoessen und zur einstellung von gegenstaenden.
ATA242390A (de) Vorrichtung zum arretieren von toren und dgl.
DE69011337D1 (de) Polyhalodihydrodioxine und polyhalodioxole.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ATE100094T1 (de) Imidazolantiarrythmische mittel.
DE59001699D1 (de) Vorrichtung zum querschneiden und querschweissen von bahnen.
DE68919512D1 (de) Chinoxalin-Derivate und antiulzerierendes Mittel.
DE3761240D1 (de) Antihypoxisches mittel.
DE69010812D1 (de) Turbolader, Vorrichtung und Antriebsmethode.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee